New stent aims to fix aortic arch without open surgery
NCT ID NCT07564375
First seen May 06, 2026
Summary
This early study tests a new device called the GORE Multibranch Arch Endoprosthesis for people with aortic arch conditions like aneurysms or dissections. The device is placed inside the blood vessel to repair the damaged area. The study will enroll 20 participants and follow them for 5 years to check if the device is safe and works as intended.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THORACIC AORTIC ANEURYSM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
GORE Multibranch Arch Endoprosthesis (MBA device) and GORE Ascending Stent Graft (ASG device)
What this could lead to
If successful, this device could offer a less invasive way to treat complex aortic arch problems, potentially avoiding open-heart surgery.
What could go wrong
This is a very early, small study (20 people) focused only on safety. The device may fail or cause serious complications like stroke or kidney failure.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.